Literature DB >> 11368878

Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma.

Y J Jung1, K H Lee, D W Choi, C J Han, S H Jeong, K C Kim, J W Oh, T K Park, C M Kim.   

Abstract

Deregulation of the cell cycle by overexpression of G1 cyclins, cyclin E and cyclin D1 genes, has been demonstrated to be a prerequisite for the development of human cancer. Recently, cyclin E is proposed to be sufficient for the progression of the G1 cell cycle without cyclin D1. Here we show that the proposed model system was specifically present in human hepatocellular carcinoma (HCC) unlike other human cancers. Of 31 HCC tissues analyzed, 21 (67.7%) exhibited an overexpression of cyclin E protein. In contrast to cyclin E gene expression, cyclin D1 expression was strongly downregulated in 19 (61.2%) HCCs. Interestingly, 65% of HCC tissues with overexpression of the cyclin E gene exhibited downregulation of cyclin D1, suggesting reciprocal deregulation of these cyclins in the G1 progression of the cell cycle. Southern blot analysis proved the amplification of cyclin E gene in HCC with a high level of overexpression. The present findings suggest that the reciprocal deregulation of cyclin E lacking cyclin D1 expression might play a role in G1 progression and the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368878     DOI: 10.1016/s0304-3835(01)00403-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

Authors:  Xuetian Yue; Zhenyu Zhang; Xiaohong Liang; Lifen Gao; Xiaoning Zhang; Di Zhao; Xiao Liu; Hongxin Ma; Min Guo; Brett T Spear; Yaoqin Gong; Chunhong Ma
Journal:  Gastroenterology       Date:  2012-03-06       Impact factor: 22.682

2.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

3.  Expression of cyclin D1 and cyclin E in urothelial bladder carcinoma detected in tissue chips using a quantum dot immunofluorescence technique.

Authors:  Guang Shan; Tian Tang
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

4.  Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.

Authors:  Azza E El Bassiouny; Mona M Nosseir; Mona K Zoheiry; Noha A Ameen; Ahmed M Abdel-Hadi; Ibrahim M Ibrahim; Suher Zada; Abdel-Hakeem Saad El-Deen; Nora E El-Bassiouni
Journal:  World J Hepatol       Date:  2010-01-27

5.  3D Chromosome Regulatory Landscape of Human Pluripotent Cells.

Authors:  Xiong Ji; Daniel B Dadon; Benjamin E Powell; Zi Peng Fan; Diego Borges-Rivera; Sigal Shachar; Abraham S Weintraub; Denes Hnisz; Gianluca Pegoraro; Tong Ihn Lee; Tom Misteli; Rudolf Jaenisch; Richard A Young
Journal:  Cell Stem Cell       Date:  2015-12-10       Impact factor: 24.633

6.  Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.

Authors:  Haksier Ehedego; Antje Mohs; Bettina Jansen; Kanishka Hiththetiya; Piotr Sicinski; Christian Liedtke; Christian Trautwein
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

7.  BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.

Authors:  Eric S Calhoun; Jessa B Jones; Raheela Ashfaq; Volkan Adsay; Suzanne J Baker; Virginia Valentine; Paula M Hempen; Werner Hilgers; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Kinase-independent function of E-type cyclins in liver cancer.

Authors:  Yan Geng; Wojciech Michowski; Joel M Chick; Yaoyu E Wang; M Emmanuelle Jecrois; Katharine E Sweeney; Lijun Liu; Richard C Han; Nan Ke; Agnieszka Zagozdzon; Ewa Sicinska; Roderick T Bronson; Steven P Gygi; Piotr Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

9.  Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency.

Authors:  Chi Luo; Jiaxin Liang; Kfir Sharabi; Maximilian Hatting; Elizabeth A Perry; Clint D J Tavares; Lipika Goyal; Amitabh Srivastava; Marc Bilodeau; Andrew X Zhu; Piotr Sicinski; Pere Puigserver
Journal:  Cancer Res       Date:  2020-06-30       Impact factor: 13.312

10.  The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.

Authors:  Xavier Bisteau; Matias J Caldez; Philipp Kaldis
Journal:  Cancers (Basel)       Date:  2014-01-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.